Prognostic survival factors in acute liver failure patients in India

Authors

1 Department of Biostatistics, St. Thomas College, Pala, Kerala, India

2 Department of Gastroenterology, PSG Hospital, Coimbatore, Tamil Nadu, India

3 Department of Community Medicine, PSG Institute of Medical Sciences and Research, Coimbatore, Tamil Nadu, India

Abstract

Background: Acute liver failure (ALF) is characterized by severe and sudden liver cell dysfunction. Baseline demographic, clinical, and biochemical factors associated with the survival of ALF patients were identified in a few selected Western studies, but very few studies have been done in India. The aim of the current study is to provide an overview of the factors associated with the survival of ALF patients and to suggest an optimum cutoff value for clinically significant parameters. Materials and Methods: The patients suffering from ALF were reviewed in this study. The factors studied were age, sex, total serum bilirubin, serum creatinine, serum albumin, urea, aspartate aminotransferase, alanine aminotransferase (ALT), and recent hepatitis E virus infection. Results: Total n = 41; Male 73%; median age 43 years. The median survival time of patients in the age group of 18–40 years was 238 days. The median survival time of patients >40 years of age was 129.10 days. Elevated serum urea and serum ALT levels at the time of admission were found to be significant predictors of mortality in patients suffering from ALF in our study. In Receiver Operator Characteristic (ROC) curve analysis, the optimum cutoff value of urea was found to be 42 mg/dL, and ALT was found to be 400 IU/L. Conclusions: Elevated serum urea and serum ALT levels at the time of admission were found to be significant predictors of mortality in patients suffering from ALF in our study. The use of these two parameters, along with King's criteria for the prognosis of ALF, can be more useful in the management of such patients in India.

Keywords

1.
Trey C, Davidson CS. The management of fulminant hepatic failure. Prog Liver Dis 1970;3:282-98.  Back to cited text no. 1
    
2.
Fontana RJ, Ellerbe C, Durkalski VE, Rangnekar A, Reddy RK, Stravitz T, et al. Two-year outcomes in initial survivors with acute liver failure: Results from a prospective, multicentre study. Liver Int 2015;35:370-80.  Back to cited text no. 2
    
3.
Ostapowicz G, Fontana RJ, Schiødt FV, Larson A, Davern TJ, Han SH, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137:947-54.  Back to cited text no. 3
    
4.
Acharya SK, Batra Y, Hazari S, Choudhury V, Panda SK, Dattagupta S. Etiopathogenesis of acute hepatic failure: Eastern versus Western countries. J Gastroenterol Hepatol 2002;17 Suppl 3:S268-73.  Back to cited text no. 4
    
5.
Saliba F, Samuel D. Acute liver failure: Current trends. J Hepatol 2013;59:6-8.  Back to cited text no. 5
    
6.
Kaite P. Kay Richard and rowell lucy. Comparing proportional hazard and accelerated failure time models: An application in Influenza. Pharmaceut Statist 2006;5:213-24.  Back to cited text no. 6
    
7.
Clark TG, Bradburn MJ, Love SB, Altman DG. Survival analysis part I: Basic concepts and first analyses. Br J Cancer 2003;89:232-8.  Back to cited text no. 7
    
8.
Bradburn MJ, Clark TG, Love SB, Altman DG. Survival analysis part II: Multivariate data analysis-an introduction to concepts and methods. Br J Cancer 2003;89:431-6.  Back to cited text no. 8
    
9.
Bradburn MJ, Clark TG, Love SB, Altman DG. Survival analysis Part III: Multivariate data analysis-choosing a model and assessing its adequacy and fit. Br J Cancer 2003;89:605-11.  Back to cited text no. 9
    
10.
Aggarwal R. Hepatitis E: Historical, contemporary and future perspectives; Journal of Gastroenterology and Hepatology, vol. 26, Jan 2011, 72-82.  Back to cited text no. 10
    
11.
O'Grady JG, Schalm SW, Williams R. Acute liver failure: Redefining the syndromes. Lancet 1993;342:273-5.  Back to cited text no. 11
    
12.
Lee WM. Acute liver failure. Semin Respir Crit Care Med 2012;33:36-45.  Back to cited text no. 12
    
13.
Polson J, Lee WM. American Association for the Study of Liver Disease. AASLD position paper: The management of acute liver failure. Hepatology 2005;41:1179-97.  Back to cited text no. 13
    
14.
O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of Prognosis in fulminant hepatic failure. Gastroenterology 1989; 97:439.  Back to cited text no. 14